DUBLIN–(BUSINESS WIRE)–The “Procurement As A Service Market Size, Share & Trends Analysis Report by Vertical…
Latest award recognizes Insight’s assistance in fueling Intel’s strong growth in the cloud space CHANDLER,…
Meeting to highlight updated data from the Phase 1/2a study of CLN-081 CAMBRIDGE, Mass., May…
Novel galectin-3-based mechanism of PD-1/PD-L1 checkpoint inhibitor resistance identified Galecto’s oral galectin-3 inhibitor candidate, GB1211,…
VANCOUVER, British Columbia, May 26, 2022 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV, the…
Ethics Committee approval received from the two sites that will conduct the SCI-110 trial in…
– Overall Response Rate of 7.7 percent is similar to checkpoint inhibitors alone – –…
CAMBRIDGE, Mass., May 26, 2022 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage…
Company to highlight novel multi-disciplinary approach to reverse the progression of both rare and common…
Phase 1 study evaluates safety, tolerability, pharmacokinetics and preliminary anti-tumor activity of YL-13027, an inhibitor…
SEATTLE and VANCOUVER, British Columbia, May 26, 2022 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc….
SEATTLE, May 26, 2022 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a…
TORONTO, May 26, 2022 (GLOBE NEWSWIRE) — ACTO, the only complete commercial learning platform for…
– EGFRxCD3-targeting bispecific is sixth CytomX Probody® therapeutic candidate to enter the clinic – SOUTH…
ROCKVILLE, Md., May 26, 2022 (GLOBE NEWSWIRE) — Innovative Cellular Therapeutics, Inc. (ICT), a clinical-stage…
Poster Presentation to highlight ongoing clinical study of CEND-1 with FOLFIRINOX-based therapies in pancreatic, colorectal…
SAN DIEGO, May 26, 2022 (GLOBE NEWSWIRE) — Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage…
First-of-its-kind solution allows manufacturing engineers to build and deploy digital twins in minutes instead of…
WOBURN, Mass., May 26, 2022 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a cloud-based…
TORONTO and GATINEAU, Québec, May 26, 2022 (GLOBE NEWSWIRE) — Converge (TSX:CTS) (FSE:0ZB) (OTCQX:CTSDF), a…